INVL Baltic Sea Growth Fund | UAB RP Pharma | UAB InMedica

The Competition Council of the Republic of Lithuania cleared with conditions an acquisition by INVL Baltic Sea Growth Fund and UAB RP Pharma of joint control of UAB InMedica in the markets for (i) the provision of paid secondary level outpatient cardiology services, (ii) the provision of paid secondary level outpatient pulmonology services, (iii) the provision of paid secondary level outpatient rheumatology services (iv) the provision of paid secondary level outpatient cardiology services and (v) the provision of paid secondary level outpatient urology services.